日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Venetoclax-Dexamethasone Versus Pomalidomide-Dexamethasone in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma: Primary Results of the Randomized, Phase III CANOVA Study

在 t(11;14) 阳性复发/难治性多发性骨髓瘤中,维奈托克-地塞米松与泊马度胺-地塞米松的疗效比较:随机 III 期 CANOVA 研究的主要结果

Popat, Rakesh; Beksac, Meral; Dimopoulos, Meletios A; Gatt, Moshe E; Gay, Francesca; Jo, Jae-Cheol; Kapoor, Prashant; Katodritou, Eirini; Kortüm, K Martin; Ling, Silvia; Nagarajan, Chandramouli; Suzuki, Kenshi; Qiu, Lugui; Onishi, Maika; Ku, Grace; Dail, Monique; Mukherjee, Nabanita; Ross, Jeremy A; Badawi, Mohamed Ali; Fusco, Mary Jean; Dobkowska, Edyta; Arriola, Emma; Bueno, Orlando F; Bahlis, Nizar J; Iida, Shinsuke; Moreau, Philippe; Valent, Jason; Mateos, María-Victoria

Pirtobrutinib Versus Ibrutinib in Treatment-Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

吡托布替尼与伊布替尼治疗初治及复发/难治性慢性淋巴细胞白血病/小淋巴细胞淋巴瘤的比较

Woyach, Jennifer A; Qiu, Lugui; Grosicki, Sebastian; Wrobel, Tomasz; Capra, Marcelo; Czyz, Jaroslaw; Yi, Shuhua; Eom, Ki-Seong; Panovská, Anna; Jurczak, Wojciech; Laribi, Kamel; Jacobasch, Lutz; Baker, Ross; Agajanian, Richy; Berkovits, Alejandro; Özcan, Muhit; Lepretre, Stéphane; Coombs, Catherine C; Cramer, Paula; Lewis, Katharine L; Hill, Marisa; Bao, Katherine; Bian, Yuanyuan; De Batista Ribeiro, Silvia Ramalho; Bhandari, Naleen Raj; Ruppert, Amy S; Leow, Ching Ching; Wierda, William G

Micro-Strain Responsive Near-Infrared Mechanoluminescence for Potential Nondestructive Artificial Joint Stress Imaging

用于潜在无损人工关节应力成像的微应变响应近红外机械发光

Li, Wenhao; Xiong, Puxian; Zheng, Xiaoxin; Niu, Luyue; Cui, Lugui; Wang, Qingyu; Viana, Bruno; Dorenbos, Pieter; Zhang, Jianzhong; Ren, Jing

Type I Interferon Pathway Activation Disrupts Monocyte Maturation and Enhances Immune Evasion in Multiple Myeloma.

I型干扰素通路激活会破坏单核细胞成熟并增强多发性骨髓瘤的免疫逃逸。

Cui Jian, Wang Jingwei, Li Xiaoyun, Wang Lina, Mao Xuehan, Lyv Rui, Yan Wenqiang, Xu Jingyu, Zhou Jieqiong, Du Chenxing, Deng Shuhui, Hao Mu, Xu Yan, Yi Shuhua, Zou Dehui, Cheng Tao, Gao Xin, Qiu Lugui, An Gang

Talquetamab, a GPRC5D×CD3 bispecific antibody, in Chinese patients with relapsed/refractory multiple myeloma: efficacy and safety from the phase 1/2 MonumenTAL-1 study

Talquetamab(一种GPRC5D×CD3双特异性抗体)治疗中国复发/难治性多发性骨髓瘤患者的疗效和安全性:来自MonumentTAL-1 1/2期研究

An, Gang; Jin, Jie; Cai, Zhen; Jing, Hongmei; Fu, Chengcheng; He, Pengcheng; Xia, Zhongjun; Liu, Rui; Li, Liang; Gai, Xue; Zhang, Hong; Zhu, Dian; Luo, Xinchao; Sun, Binbin; Xu, Hongmei; Zhou, Longen; Campagna, Michela; Masterson, Tara J; Lau, Bonnie W; Renaud, Thomas; Heuck, Christoph; Singh, Indrajeet; Vishwamitra, Deeksha; Qiu, Lugui

Who is at risk? Clinical features and a predictive model for 30-day mortality in hematologic patients with enterococcal bloodstream infection

哪些人面临风险?血液病患者肠球菌血流感染的临床特征及30天死亡率预测模型

Yang, Nuobing; Zhen, Sisi; Zhang, Tingting; Fan, Yuping; Lin, Qingsong; Mi, Yingchang; Zheng, Yizhou; Qiu, Lugui; Zhang, Fengkui; Jiang, Erlie; Han, Mingzhe; Xiao, Zhijian; Wang, Jianxiang; Feng, Sizhou; Chen, Xin

A comprehensive analysis of pirtobrutinib in Chinese patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL): Results from the phase 3 study BRUIN CLL-321

对中国慢性淋巴细胞白血病/小淋巴细胞淋巴瘤 (CLL/SLL) 患者使用吡托布替尼的综合分析:来自 3 期研究 BRUIN CLL-321 的结果

Yi, Shuhua; Cao, Jiang; Feng, Ru; Zhou, Keshu; Qiu, Lihua; Li, Fei; Yang, Hai Yan; Zhou, Hui; Hui, Wuhan; Cui, Jie; Huang, He; Zhu, Jiankun; Ye, Xiuhui; Sharman, Jeff; Qiu, Lugui

Respiratory and blood samples metagenomic sequencing in diagnosing pulmonary infections in hematologic patients

呼吸道和血液样本宏基因组测序在血液病患者肺部感染诊断中的应用

Xu, Chunhui; Zhang, Lining; Liu, Teng; Zhu, Guoqing; Wei, Hui; Zheng, Yizhou; Shi, Jun; Qiu, Lugui; Xiao, Zhijian; Zhu, Xiaofan; Wang, Jianxiang; Guo, Jian; Fan, Yuping; Song, Yijun; Jiang, Erlie; Feng, Sizhou

Thalidomide-based regimen shows promising efficacy in large granular lymphocytic leukemia: a multicenter phase II study

一项多中心 II 期研究显示,基于沙利度胺的治疗方案在治疗大颗粒淋巴细胞白血病方面显示出良好的疗效。

Yu, Ying; Li, Yuxi; Cui, Rui; Yan, Yuting; Li, Fei; Chen, Yan; Wang, Tingyu; Hu, Xiaoli; Feng, Yaqing; Yu, Tengteng; Huang, Yanshan; Sun, Jingwen; Lyu, Rui; Xiong, Wenjie; Wang, Qi; Liu, Wei; An, Gang; Sui, Weiwei; Xu, Yan; Huang, Wenyang; Zou, Dehui; Wang, Huijun; Xiao, Zhijian; Wang, Jianxiang; Qiu, Lugui; Yi, Shuhua

Phase III Trial of Pirtobrutinib Versus Idelalisib/Rituximab or Bendamustine/Rituximab in Covalent Bruton Tyrosine Kinase Inhibitor-Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-321)

在共价布鲁顿酪氨酸激酶抑制剂预处理的慢性淋巴细胞白血病/小淋巴细胞淋巴瘤中,Pirtobrutinib 与 Idelalisib/Rituximab 或 Bendamustine/Rituximab 的 III 期试验 (BRUIN CLL-321)

Sharman, Jeff P; Munir, Talha; Grosicki, Sebastian; Roeker, Lindsey E; Burke, John M; Chen, Christine I; Grzasko, Norbert; Follows, George; Mátrai, Zoltán; Sanna, Alessandro; Qiu, Lugui; Feng, Ru; Hua, Vu Minh; Jurczak, Wojciech; Ritgen, Matthias; Yi, Shuhua; Bosch, Francesc; Coombs, Catherine C; Bao, Katherine; Patel, Vishalkumar; Liu, Bin; Compte, Livia; Guntur, Ananya; Wang, Denise Y; Hill, Marisa; Leow, Ching Ching; Ghia, Paolo; Barr, Paul M